MarketInOut Stock Screener Log In | Sign Up

9 Meters Biopharma Inc

OTC • Healthcare • Biotechnology • Quote as of 11/16/2026 09:31
9 Meters Biopharma Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization0.001445 mln
Float14.22 mln
Earnings Date08/13/2026

Relative Strength

100 / 100
Top performer

ROE

-376
Deeply negative

ROA

-112
Deeply negative

Business Description

9 Meters Biopharma was a clinical-stage company based in Raleigh, North Carolina, that worked on treatments for rare and serious digestive conditions affecting patients in North America. Its pipeline included several drug candidates targeting conditions such as short bowel syndrome, obesity, and complications from organ transplants, with its lead therapy, Vurolenatide, having reached Phase 3 clinical trials. The company also held licensing agreements with multiple partners and was co-developing Larazotide for multi-system inflammatory syndrome. In July 2023, the company sought court approval to wind down its operations through a Chapter 7 bankruptcy filing.

Key Fundamentals

EPS-3.46
ROE-376
ROA-112
EBITDA, mln-43.43
EV / EBITDA0.04

Quote Details

Last 0.000001
Change -0.000099 (-99%)
Open 0.000001
Volume 155
Turnover 0.000155
Average Volume 2,421.29

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0% 100 / 100   
1 Month 0% 100 / 100   
2 Months 0% 100 / 100   
6 Months 0% 100 / 100   
1 Year 0% 100 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog